However, numerous authors have reported that PPAR gamma agonists produce favorable effects in Alzheimer's disease, both in man and transgenic animal models, but this may well be due to their anti-inflammatory properties. The gene discussed is PPARG; the disease is early-onset autosomal dominant Alzheimer disease.